All In Biotech

Drug Trial Radar · NCT07588100

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

A Multicenter, Non-Randomized, Open-Label, Multiple-Ascending-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jun 18, 2026

Primary completion

Jan 20, 2028

Study completion Jan 20, 2028

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
May 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety, tolerability, and pharmacokinetics (PK) of intravitreal (IVT) injections of RO7663498 in participants with diabetic retinopathy (DR).

Conditions

  • Diabetic Retinopathy

Interventions

  • RO7663498Drug

    Participants will receive RO7663498 as per the schedule defined in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Ocular Adverse Events (AEs)Time frame: Up to Week 20
  2. Percentage of Participants With Systemic (non-ocular) AEsTime frame: Up to Week 20
  3. Number of Abnormalities Recorded in Standard Ophthalmological AssessmentsTime frame: Up to Week 20

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Global Research Management

    Glendale, California · Recruiting

  • University Retina and Macula Associates, PC

    Oak Forest, Illinois · Recruiting

  • Ohio State Havener Eye Institute;Ophthalmology Research

    Columbus, Ohio · Recruiting

  • Medical Center Ophthalmology Associates

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.